IDiyas

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

Eddie V Tao

USPTO Granted Patents = 14

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 44(Granted Patents)


Location History:

  • Carmel, IN (US) (1992 - 1995)
  • Indianapolis, IN (US) (1982 - 1997)

Company Filing History:

goldMedal14 out of 4,442 
 
Eli Lilly and Company
 patents

Years Active: 1982-1997

Loading Chart...
14 patents (USPTO):Explore Patents
1. 5637692 - Azetidinone intermediates to carbacephalosporins and process (1997-06-10),
2. 5594028 - Anti-tumor method and compounds (1997-01-14),
3. 5453503 - Azetidinone intermediates to carbacephalosporins and process (1995-09-26),
4. 5387681 - Synthesis of bicyclic aromatic sulfonic acids sulfonyl chlorides and (1995-02-07),
5. 5225553 - Intermediates to 1-carbacephalosporins and process for preparation (1993-07-06),
6. 5159073 - Intermediates to 1-carbacephalosporins and process for preparation (1992-10-27),
7. 4924001 - Process for preparing 5-cyano-4, 5-dihydro-3,4-dicarboxypyrazole (1990-05-08),
8. 4921947 - Process for preparing macrolide derivatives (1990-05-01),
9. 4892956 - 5-cyano-4,5-dihydro-3,4-dicarboxypyrazole derivatives (1990-01-09),
10. 4820845 - Alkylation of 3(5)-cyano-1H-pyrazole-4-carboxylic acid esters (1989-04-11),
11. 4587348 - Process for preparing herbicidal (1986-05-06),
12. 4394510 - Process for preparing an isoxazolylurea (1983-07-19),
13. 4346225 - Herbicidal 2-methylamino thiadiazolines (1982-08-24),
14. 4338449 - Herbicidal thiadiazolines (1982-07-06),

Title: Eddie V Tao: Innovator in Pharmaceutical Chemistry

Introduction

Eddie V Tao is a prominent inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 14 patents. His work focuses on developing innovative compounds and methods that have the potential to impact medical treatments.

Latest Patents

Among his latest patents, Eddie V Tao has developed azetidinone intermediates to carbacephalosporins. This process involves the creation of 7.beta.-amino-3-hydroxy-1-carba(1-dethia)-3-cephem-4-carboxylic acid esters through the cyclization of cis-3-(substituted amino)-1-(2-substituted 2-oxoethyl)-4-substituted azetidinones. These esters serve as useful chiral intermediates for .beta.-lactam antibiotics. Additionally, he has patented an anti-tumor method and compounds that provide certain sulfonamide derivatives, their pharmaceutical formulations, and their application in treating susceptible neoplasms in mammals.

Career Highlights

Eddie V Tao is associated with Eli Lilly and Company, where he continues to contribute to advancements in pharmaceutical research. His innovative work has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Throughout his career, Eddie has collaborated with notable colleagues, including James A Aikins and John Robert Rizzo. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Eddie V Tao's contributions to pharmaceutical chemistry through his numerous patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…